Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line

Cell Biology International

Volumn 37, Issue 7, 2013, Pages 669-674

  Cai, Zhi Gang ^a   Zhang, Shao Ming ^a   Zhang, Hang ^a   Zhou, Yi Yong ^a   Wu, Hai Bo ^a   Xu, Xiao Ping ^a  

^a People's Liberation Army 455 Hospital   (China)

Author keywords

Emt; Ht 29; Mir 200b; Mirna; Zeb1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MICRORNA; MICRORNA 181; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 214; MICRORNA 22; MICRORNA 26; MICRORNA 27; MICRORNA 30; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST1; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; UPREGULATION;

EID: 84880702318     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10087     Document Type: Article

References (43)

1. Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, Sarkar FH, Raz A (2011) Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res 71(9): 3400-9.
2. Aslam MI, Patel M, Singh B, Jameson JS, Pringle JH (2012) MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application. J Transl Med 10(1): 128
3. Bhatti I, Lee A, Lund J, Larvin M (2009) Small RNA: a large contributor to carcinogenesis?. J Gastrointest Surg 13(7): 1379-88.
4. Castilla MA, Moreno-Bueno G, Romero-Perez LVan De Vijver K, Biscuola M, Lopez-Garcia MA, Prat J, Matias-Guiu X, Cano A, Oliva E, Palacios J (2011) Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 223(1): 72-80
5. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, et al. (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13(3): 317-23
6. Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF (2011) Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol Oncol 121(1): 200-5
7. Chui MH (2013) Insights into cancer metastasis from a clinicopathologic perspective: epithelial-mesenchymal transition is not a necessary step. Int J Cancer 132(7): 1487-95
8. du Rieu MCTorrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrere N, Buscail L, et al. (2010) MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem 56(4): 603-12
9. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q (2011) miR- 200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 286(29): 25992-6002
10. Gill JG, Langer EM, Lindsley RC, Cai M, Murphy TL, Kyba M, Murphy KM (2011) Snail and the microRNA-200 family act in opposition to regulate epithelial-to-mesenchymal transition and germ layer fate restriction in differentiating ESCs. Stem Cells 29(5): 764-76
11. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, et al. (2011) An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 22(10): 1686-98
12. Guttilla IK, Adams BD, White BA (2012) ERalpha, microRNAs, and the epithelial-mesenchymal transition in breast cancer. Trends Endocrinol Metab 23(2): 73-82
13. Howe EN, Cochrane DR, Richer JK (2011) Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13(2): R45
14. Jahid S, Sun J, Edwards RA, Dizon D, Panarelli NC, Milsom JW, Sikandar SS, Gumus ZH, Lipkin SM (2012) miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov 2(6): 540-53
15. Kahlert C, Lahes S, Radhakrishnan P, Dutta S,Mogler C, Herpel E, Brand K, Steinert G, Schneider M,Mollenhauer M, et al. (2011) Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clin Cancer Res 17(24): 7654-7663
16. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, et al. (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 208(5): 875-83
17. KongW, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ (2008) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28(22): 6773-84
18. Liu B, Li J, Tsykin A, Liu L, Gaur AB, Goodall GJ (2009) Exploring complex miRNA-mRNA interactions with Bayesian networks by splitting-averaging strategy. BMC Bioinformatics 10: 408
19. Liu J, Luo XJ, Xiong AW, Zhang ZD, Yue S, Zhu MS, Cheng SY (2010a) MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via downregulation of protooncogene N-ras. J Biol Chem 285(34): 26599-607
20. Liu L, Chen L, Xu Y, Li R, Du X (2010b) microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 400(2): 236-40
21. Loboda A,NebozhynMV,Watters JW, Buser CA, Shaw PM,Huang PS, Van't Veer L, Tollenaar RA, Jackson DB, Agrawal D, et al. (2011) EMT is the dominant program in human colon cancer. BMC Med Genomics 4: 9
22. Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA,Nakagawa M, Darling DS, BasuD, et al. (2011) A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 71(21): 6836-47
23. Okada H, Kohanbash G, Lotze MT (2010) MicroRNAs in immune regulation-opportunities for cancer immunotherapy. Int J Biochem Cell Biol 42(8): 1256-61
24. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A, Ouelaa R, Bracke M, DeWever O, Gespach C (2008) Molecular signature and therapeutic perspective of the epithelial-tomesenchymal transitions in epithelial cancers. Drug Resist Updat 11(4-5): 123-51
25. Schickel R, Park SM, Murmann AE, Peter ME (2010) miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell 38(6): 908-15
26. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, et al. (2011) Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 71(24): 7670-82
27. Smit MA, Peeper DS (2008) Deregulating EMT and senescence: double impact by a single twist. Cancer Cell 14(1): 5-7
28. Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE (2011) MicroRNA Control of Invasion and Metastasis Pathways. Front Genet 2: 58
29. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat RevMol Cell Biol 7(2): 131-42
30. Tryndyak VP, Beland FA, Pogribny IP (2010) E-cadherin transcriptional downregulation by epigenetic and microRNA- 200 family alterations is related to mesenchymal and drugresistant phenotypes in human breast cancer cells. Int J Cancer 126(11): 2575-83
31. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, Cooper ME, et al. (2011) miR-200a Prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 60(1): 280-7
32. Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY, Shen SR (2010) Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 345(1-2): 283-90
33. Wang Z, Wei W, Sarkar FH (2012) miR-23a, a critical regulator of 35"migR"ation and metastasis in colorectal cancer. Cancer Discov 2(6): 489-91
34. Wurz K, Garcia RL, Goff BA, Mitchell PS, Lee JH, Tewari M, Swisher EM (2010) MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer 49(7): 577-84
35. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J (2012) The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 302(3): F369-79
36. Yamakuchi M, Yagi S, Ito T, Lowenstein CJ (2011) MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS ONE 6 (5): e20291
37. Yang D, Torres CM, Bardhan K, Zimmerman M, McGaha TL, Liu K (2012) Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo. J Immunol 188(9): 4441-9
38. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7): 927-39
39. Yang Z, Chen S, Luan X, Li Y, Liu M, Li X, Liu T, Tang H (2009) MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 61(11): 1075-82
40. Yang Z, Zhang X, Gang H, Li X, Li Z,Wang T, Han J, Luo T,Wen F, Wu X (2007) Upregulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochem Biophys Res Commun 358(3): 925-30
41. Zavadil J, Narasimhan M, Blumenberg M, Schneider RJ (2007) Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185 (1-3): 157-61.
42. Zhang G, Xia S, Tian H, Liu Z, Zhou T (2012a) Clinical significance of miR-22 expression in patients with colorectal cancer. Med Oncol 29(5): 3108-12.
43. Zhang J, Xiao Z, Lai D, Sun J, He C, Chu Z, Ye H, Chen S, Wang J (2012b) miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer 107(2): 352-9.